SMBG Protocols Predicting Glucose Levels in Senior Diabetes Mellitus With CAD
Diabetes Mellitus, Type 2, Coronary Artery Disease
About this trial
This is an interventional diagnostic trial for Diabetes Mellitus, Type 2 focused on measuring Diabetes mellitus, Coronary artery disease, SMBG, Elderly
Eligibility Criteria
Inclusion Criteria:
- Clinical diagnosis of type 2 diabetes
- Clinical diagnosis of coronary artery disease
- Age ≥65 years
- The blood glucose is controlled by diets and (or) oral hypoglycemic drugs
- BMI≤28 kg/m²
- Being able to monitor and record capillary glucose value by themselves at home
Exclusion Criteria:
- Diabetic ketoacidosis (DKA)
- Acute cardiovascular events
- Anemia
- Insulin treatment
- Incapable to perform SMBG at home
Sites / Locations
- Capital Medical University Affiliated Beijing Anzhen Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
Control Group
SMBG-4 Group
SMBG-7 Group
Patients will receive conventional care and keep on their usual SMBG(Self-monitoring of blood glucose) methods. Additionally, each patient will also wear a CGMS(continous glucose monitoring system) device for 72h in the first week and the last week, respectively.
Capillary glucose level is measured using finger stick method by 4 times (fasting plus post-meals) every other day. Additionally, each patient will also wear a CGMS device for 72h in the first week and the last week, respectively.
Capillary glucose level is measured using finger stick method by 7 times (fasting, pre-meals, post-meals and bedtime altogether) every other day. Additionally, each patient will also wear a CGMS device for 72h in the first week and the last week, respectively.